Skytrofa

lonapegsomatropin-tcgd

Approval

ApplicationBLA 761177
Approval dateAug 25, 2021
Approval year2021
SponsorAscendis Pharma Encocrinology Div A/S

FDA-approved use

To treat short stature due to inadequate secretion of endogenous growth hormone

Approval package

Query with Claude

The fda-analyst skill answers natural-language questions about this approval by fetching the relevant FDA review PDFs at query time.

git clone https://github.com/cbetz/trove
cp -r trove/skills/fda-analyst ~/.claude/skills/

Example prompts for Skytrofa: